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Objective: We analyzed the angiographic changes of the anastomotic sites at three
time points for 5 years after off-pump coronary artery bypass surgery.
Methods: Of the 402 patients who underwent off-pump coronary artery bypass sur-
gery between January 1998 and December 2001, 240 patients who received the early,
1-year, and 5-year follow-up coronary angiograms regardless of the patient’s anginal
symptoms were studied. Morphologic changes of grafts were traced by the FitzGib-
bon grading system.
Results: Overall graft patency rates (FitzGibbon grade A1B) at early, 1-year, and
5-year angiography were 98.6%, 91.9%, and 88.3%, respectively. Graft patency rates
in the left anterior descending artery, left circumflex artery, and right coronary artery
territories were similar at early angiograms (P5 .162). However, graft patency rate in
the left anterior descending artery territory was higher than that in the left circumflex
artery and right coronary artery territories at both the 1-year (P , .001) and 5-year
(P, .001) angiograms. Of the 31 FitzGibbon grade B arterial grafts (internal thoracic
artery and right gastroepiploic artery) at early angiography, 10 became occluded and
19 became grade A at 5-year angiography. In the saphenous vein grafts, grade B le-
sions gradually increased during the 5 postoperative years (2.6% vs 6.5% vs 13.3%).
Conclusions: Midterm angiographic follow-up demonstrated acceptable patency rates
of grafts after off-pump coronary artery bypass surgery. Approximately half of the
FitzGibbon grade B arterial grafts in the early angiograms became grade A at 5 years
after surgery, but the proportion of grade B saphenous vein grafts gradually increased
over the 5 postoperative years.
S
everal studies have investigated the patency rates of grafts after conventional
on-pump coronary artery bypass grafting (CABG) and have shown that arterial
grafts have better patency than vein grafts.1,2 With resurgent interest in off-
pump coronary artery bypass grafting (OPCAB) since the mid-1990s, there have
been concerns about accuracy and patency of the grafts and the long-term outcome.
Some meta-analyses demonstrated that patients undergoing OPCAB demonstrated
a lower graft patency than patients undergoing conventional CABG.3,4 Another
meta-analysis5 demonstrated a statistically insignificant benefit of conventional
CABG over OPCAB for arterial graft patency. However, most of these studies
were cross-sectional investigations performed at a defined point in time after surgery.
The aims of this study included (1) serial comparison of the graft patency rates in
patients who had undergone angiography early postoperatively and 1 and 5 years after
OPCAB, (2) evaluation of the graft patency rates based on target territories and revas-
cularization strategies during the 5 postoperative years, and (3) assessment of the
serial changes of FitzGibbon B stenotic grafts during the 5 postoperative years.
Patients and Methods
Among the total 522 patients who underwent isolated CABG between January 1998 and
December 2001, OPCAB was performed in 402 (77.0%) patients. Operative mortality
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CDAbbreviations and Acronyms
CABG 5 coronary artery bypass grafting
ITA 5 internal thoracic artery
LAD 5 left anterior descending coronary artery
LCX 5 left circumflex artery
OPCAB 5 off-pump coronary artery bypass grafting
RCA 5 right coronary artery
RGEA 5 right gastroepiploic artery
(#30 days) of the OPCAB patients was 1.24% (5/402). There were
8 late in-hospital deaths (.30 days) and 16 additional deaths during
the 5-year follow-up. The early, 1-year, and 5-year follow-up coro-
nary angiograms were performed regardless of the patients’ anginal
symptoms in 384, 349, and 262 patients, respectively. Of the
402 OPCAB patients, 240 (59.7%) patients who received all the
early (postoperative day 1.6 6 1.6), 1-year (postoperative month
13.2 6 5.2), and 5-year (postoperative month 59.9 6 5.7) follow-
up angiograms were studied for evaluation of the anastomotic sites
and patency of the grafts (Table 1). Patients who died, refused angio-
graphic evaluation, or had renal function impairment were excluded
from the angiographic follow-up. However, patients with renal re-
placement therapy were included in the angiographic follow-up.
Follow-up coronary angiography included 4-plane selective coro-
nary and bypass graft angiography. One physician initially reviewed
all the coronary angiograms and consensus was reached after
review.
Graft patency was graded as described by FitzGibbon, Burton,
and Leach6 (grade A5 excellent; grade B5 fair; grade A1B5 pat-
ent). Competitive graft flow was defined as distal graft as well as dis-
tal native grafted coronary artery flow not clearly opacified as seen
TABLE 1. Preoperative characteristics and risk factors of
study patients
Patient characteristics n 5 240
Sex (male/female) 158/82
Age (y) 61 6 9
Unstable/stable angina 191/49
Risk factors, n (%)
Hypertension 144 (60.0)
Diabetes mellitus 83 (34.6)
Hyperlipidemia 63 (23.6)
Previous PCI 28 (11.7)
History of stroke 27 (11.3)
LVEF ,35% 13 (5.4)
Chronic renal failure 5 (2.1)
Urgent/emergency operation 33 (13.8)
Angiographic diagnosis, n (%)
Three-vessel disease 148 (61.7)
Two-vessel disease 57 (23.8)
Left main disease with or without peripheral
disease
64 (26.7)
PCI, Percutaneous coronary intervention; LVEF, left ventricular ejection
fraction.The Journal of Thoby graft angiography, but well-visualized graft flow retrogradely as
seen by native coronary angiography; it was classified as a grade B
anastomosis.
The basic surgical procedures and principles of OPCAB have
been previously described.7 All patients halted aspirin therapy
(300 mg/day) the day before the operation and resumed it 1 day
postoperatively. The average number of distal anastomoses per pa-
tient was 3.1 6 1.0. The grafts used for distal anastomoses were
left internal thoracic artery (ITA) (n 5 234), right ITA (n 5
164), right gastroepiploic artery (RGEA) (n 5 79), radial artery
(n 5 6), and saphenous vein (n 5 57). Almost all of the left
ITA grafts (232/234), half of the right ITA grafts (94/164), and
the majority of RGEA grafts (74/79) were used as an in situ graft.
The majority of ITA grafts (93.4%, 492/527) were used to revascu-
larize the left coronary artery territory, and the majority of RGEA
grafts (92.5%, 74/80) were used to revascularize the right coronary
artery (RCA) territory. Saphenous vein grafts were used to revas-
cularize the left anterior descending artery (LAD) territory
(24.8%, 30/121), left circumflex artery (LCX) territory (40.5%,
49/121), and RCA territory (34.7%, 42/121) without any prefer-
ence (Table 2). During the study period, we changed revasculariza-
tion strategies on the basis of our early patency study after
OPCAB.8 Forty-nine (86.0%) of the 57 patients who received
vein grafts underwent OPCAB before 2000, and 77.6% (142/
183) of the patients who received total arterial grafts underwent
OPCAB after 2000.
The operations were all performed by a single surgeon (K.-B. K.).
The study protocol was reviewed by the institutional review
board and approved as a minimal risk retrospective study (Approval
No. H-0701-051-196) that did not require individual consent
according to the institutional guidelines for waiving consent.
Statistical Analysis
Statistical analysis was performed with the SPSS software
package (version 11.0; SPSS, Inc, Chicago, Ill). Comparison
of the patency rates between the grafts was performed by the
c2 test (Pearson c2 and Fisher exact tests). In the analysis of
the serial changes over the 5 years’ duration, nonparametric
c2 test with McNemar examination was used. All results
were expressed as mean 6 standard deviation or as propor-
tions.
TABLE 2. Grafts and their target coronary arteries
LAD D RI OM RCA PDA PLB Total
ITA 222 100 29 141 17 15 3 527
Left ITA 148 74 17 69 1 309
Right ITA 74 26 12 72 17 15 2 218
RGEA 6 13 59 2 80
Radial artery 1 2 1 4 1 9
Saphenous vein 7 23 6 43 20 19 3 121
Total 230 125 36 194 50 93 9 737
LAD, left anterior descending coronary artery; D, diagonal branch of the
LAD; RI, ramus intermedius; OM, obtuse marginal branch of circumflex
coronary artery; RCA, right coronary artery; PDA, posterior descending
coronary artery; PLB, posterolateral branch of right coronary artery; ITA,
internal thoracic artery; RGEA, right gastroepiploic artery.racic and Cardiovascular Surgery c Volume 135, Number 2 301
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Serial Angiographic Patency Rates of the Grafts
Overall postoperative graft patency rates (FitzGibbon grade
A1B) at early, 1-year, and 5-year follow-ups decreased sig-
nificantly (98.6% vs 91.9% vs 88.3%; P , .001). Although
ITA grafts demonstrated a greater than 90% patency rate at
5 years postoperatively, the patency rate decreased signifi-
cantly during the follow-up period (99.4% vs 95.6% vs
92.4%; P , .001). RGEA grafts showed a significantly
decreased patency rate between 1 and 5 years (91.3% vs
82.5%; P 5 .016). Saphenous vein grafts showed a signifi-
cantly decreased patency rate during the first postoperative
year (95.9% vs 76.0%; P , .001); however, the patency
rate remained stable between 1 and 5 years (76.0% vs
74.4%; P 5 .250) (Table 3).
Graft Patency Rates According to Target Coronary
Artery Territories
We defined target territories as the LAD territory, which in-
cludes the LAD or diagonal branches; the LCX territory,
which includes the ramus intermedius or obtuse marginal
branches; and the RCA territory, which includes the RCA,
posterior descending artery, or posterolateral branch. Graft
patency rates in the LAD, LCX, and RCA territories were
similar at early postoperative angiography. However, graft
patency rates of the LAD territory became higher than those
of the LCX or RCA territories at 1-year and 5-year angiogra-
phy. There were no significant differences in the graft pa-
tencies between the LCX and RCA territories until 5 years
after OPCAB (Table 4, A).
In the LAD territory, there were no significant differences
in graft patency rates between early and 1 year postopera-
tively and between 1 year and 5 years postoperatively. Al-
though the number of saphenous vein grafts for the LAD
territory was small, they also demonstrated stable patency
(100% vs 83.3% vs 83.3%: P 5 .052) (Table 4, B).
In the LCX territory, patency rates of ITA grafts decreased
significantly between early and 1 year postoperatively, and
TABLE 3. Serial angiographic patency rates
Early (n 5 240)
One year
(n 5 240)
Five years
(n 5 240)
Total 98.6% (727/737) 91.9% (677/737)* 88.3% (651/737)y
ITA 99.4% (524/527) 95.6% (504/527)* 92.4% (487/527)y
Left ITA 99.4% (307/309) 95.5% (295/309)* 91.9% (284/309)x
Right ITA 99.5% (217/218) 95.9% (209/218)z 93.1% (203/218)x
RGEA 97.5% (78/80) 91.3% (73/80) 82.5% (66/80)x
Radial artery 100% (9/9) 88.9% (8/9) 88.9% (8/9)
Saphenous
vein
95.9% (116/121) 76.0% (92/121)* 74.4% (90/121)
ITA, Internal thoracic artery; RGEA, right gastroepiploic artery. *P , .001
between early and 1 year postoperatively. yP , .001 between 1 year and
5 years postoperatively. zP, .05 between early and 1 year postoperatively.
xP , .05 between 1 year and 5 years postoperatively.302 The Journal of Thoracic and Cardiovascular Surgery c Febetween 1 year and 5 years postoperatively, and they may
be affected by the left ITA graft patency rate. The left ITA
graft patency rate decreased significantly between early and
1 year postoperatively (P 5 .004), and between 1 year and
5 years postoperatively (P5 .031). The patency rate of saphe-
nous vein grafts decreased significantly during the first post-
operative year (from 91.8% to 71.4%; P 5 .002), whereas it
remained stable between 1 and 5 years (Table 4, C).
In the RCA territory, ITA grafts demonstrated stable pa-
tency rates during the 5 postoperative years. RGEA graft pa-
tency rates decreased significantly between 1 year and 5 years
postoperatively (90.5% vs 81.1%; P5.048). Saphenous vein
TABLE 4. Serial changes of graft patency rates according
to target coronary artery territories
A. Overall graft patency rates
LAD territory LCX territory RCA territory P value
Early 99.4%
(353/355)
97.8%
(225/230)
98.0%
(149/152)
.162
One year 96.9%
(344/355)
87.8%
(202/230)*
86.2%
(131/152)*
,.001
Five years 94.9%
(337/355)
83.0%
(191/230)*
80.9%
(123/152)*
,.001
B. LAD territory
Early One year Five years
ITA 99.4% (320/322) 98.1% (316/322) 96.0% (309/322)
Left ITA 99.5% (221/222) 98.2% (218/222) 95.9% (213/222)
Right ITA 99.0% (99/100) 98.0% (98/100) 96.0% (96/100)
Radial artery 100% (3/3) 100% (3/3) 100% (3/3)
Saphenous vein 100% (30/30) 83.3% (25/30) 83.3% (25/30)
C. LCX territory
Early One year Five years
ITA 99.4% (169/170) 91.2% (155/170)y 87.1% (148/170)z
Left ITA 98.8% (85/86) 88.4% (76/86)y 81.4% (70/86)z
Right ITA 100% (84/84) 94.0% (79/84) 92.9% (78/84)
RGEA 100% (6/6) 100% (6/6) 100% (6/6)
Radial artery 100% (5/5) 80.0% (4/5) 80.0% (4/5)
Saphenous
vein
91.8% (45/49) 71.4% (35/49)y 67.3% (33/49)
D. RCA territory
Early One year Five years
ITA 100% (35/35) 94.3% (33/35) 85.7% (30/35)
Left ITA 100% (1/1) 100% (1/1) 100% (1/1)
Right ITA 100% (34/34) 94.1% (32/34) 85.3% (29/34)
RGEA 97.3% (72/74) 90.5% (67/74) 81.1% (60/74)z
Radial artery 100% (1/1) 100% (1/1) 100% (1/1)
Saphenous vein 97.6% (41/42) 76.2% (32/42)y 76.2% (32/42)
LAD, Left anterior descending coronary artery; LCX, left circumflex cororo-
nary artery; ITA, internal thoracic artery; RGEA, right gastroepiploic artery.
*P , .001 when compared with LAD territory. yP , .05 between early and
1 year postoperatively. zP,.05 between 1 year and 5 years postoperatively.bruary 2008
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the first postoperative year (from 97.6% to 76.2%; P 5
.001), but remained stable between 1 and 5 years (Table 4,D).
Changes of the Graft Patency Based on Proximal
Techniques
Distal anastomoses constructed with in situ left ITA grafts
showed progressively decreased patency rates during the 5
postoperative years, whereas distal anastomoses done with
in situ right ITA grafts showed no significant differences in
patency rates. Distal anastomoses with the composite right
ITA connected to the side of the in situ left ITA showed a de-
creased patency rate during the first postoperative year
(100% vs 95.1%; P5 .029), whereas patency showed no sig-
nificant difference between 1 and 5 years after OPCAB
(95.1% vs 92.7%; P 5 .596). Although distal anastomoses
made with in situ RGEA grafts showed no significant differ-
ences in patency rates during the first postoperative year, pa-
tency decreased significantly between 1 and 5 years after
OPCAB. Distal anastomoses with saphenous vein grafts con-
nected to the ascending aorta showed a significantly de-
creased patency rate during the first year, whereas patency
remained stable between 1 and 5 years (Figure 1).
Fates of FitzGibbon Grade B Lesions
The arterial grafts (ITA and RGEA) demonstrated 31, 32, and
33 FitzGibbon grade B grafts in the early, 1-year, and 5-year
angiograms, respectively. The proportions of grade B grafts
out of patent grafts were as follows: 5.1% (31/602) versus
5.5% (32/577) versus 6.0% (33/553) (P 5 not significant).
The ITA grafts demonstrated 23 FitzGibbon grade B grafts,
26 grade B grafts, and 29 grade B grafts in the early, 1-
year, and 5-year angiograms, respectively (4.4% [23/524]
Figure 1. Changes of graft patency based on proximal techniques.
ITA, Internal thoracic artery; RGEA, right gastroepiploic artery.
*P < .05 between early and 1 year postoperatively; **P < .05 be-
tween 1 year and 5 years postoperatively; yP< .001 between early
and 1 year postoperatively; yyP< .001 between 1 year and 5 years
postoperatively.The Journal of Thorvs 5.2% [26/504] vs 6.0% [29/487]; P 5 not significant).
Thirteen of the 23 grade B ITA grafts showed anastomotic
stenosis and the other 10 showed competitive flow patterns
in the early angiograms. Of the 13 anastomotic grade B
ITA grafts seen in the early angiograms, 9 became grade A
and 2 became occluded whereas 2 remained grade B by the
5-year angiograms. Of the 10 competitive grade B ITA grafts
seen in the early angiograms, 5 became grade A and 5 be-
came occluded by the 5-year angiograms. Six of the 7 oc-
cluded ITA grafts (grade O) by the 5-year angiograms were
associated with moderate stenosis (,80%) of the native ves-
sel. There were 20 newly developed FitzGibbon grade B ITA
grafts at the 1-year angiograms. Nineteen of the 20 grafts
showed competitive flow patterns and the other 1 showed
anastomotic stenosis. Of the 19 competitive grade B ITA
grafts seen at the 1-year angiograms, 5 became grade A
and 3 became occluded whereas 11 remained grade B by
the 5-year angiograms. All 3 of the occluded ITA grafts in
the 5-year angiograms were associated with moderate steno-
sis (,80%) of the native vessel (Figure 2).
RGEA grafts demonstrated 8 FitzGibbon grade B grafts, 6
grade B grafts, and 4 grade B grafts in the early, 1-year, and
5-year angiograms, respectively (10.3% [8/78] vs 8.2% [6/
73] vs 6.1% [4/66]; P 5 not significant). Of the 8 grade B
RGEA grafts in the early angiograms, 5 became grade A
and 3 became occluded at 5 years after surgery. Two of the
3 occluded RGEA grafts were associated with moderate ste-
nosis (,80%) of the native vessel. Seven of the 8 grade B
Figure 2. Fate of FitzGibbon grade B internal thoracic artery grafts.acic and Cardiovascular Surgery c Volume 135, Number 2 303
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1 showed anastomotic stenosis. Of the 7 competitive grade B
RGEA grafts seen at early angiography, 4 became grade A
and 3 became occluded by 5-year angiography. Three newly
developed FitzGibbon grade B RGEA grafts at 1 year
remained grade B by the 5-year angiograms.
In the saphenous vein grafts, the proportion of grade B le-
sions out of patent grafts gradually increased during the 5
postoperative years (2.6% [3/116] vs 6.5% [6/92] vs 13.3%
[12/90]; P (early vs 5-year)5 .006). All 3 of the grade B sa-
phenous vein grafts in the early angiograms demonstrated
a stenosis of greater than 50% at the distal anastomosis site
and they became grade A at 1 year after surgery. All 6 of
the newly developed grade B saphenous vein grafts seen in
1-year angiograms demonstrated segmental narrowings in
the graft trunk. Of the 6 grade B vein grafts in 1-year angio-
grams, 5 remained grade B and 1 became occluded by 5 years
after surgery.
Recurrence of Angina
During the first postoperative year, 10 (4.2%) patients expe-
rienced the recurrence of angina. Stenosis or occlusion of
a graft was associated with the recurrence of angina in 6 pa-
tients, and progression of the native coronary artery disease
was the cause of angina in 4 patients whose grafts were all
widely patent. During the study period between postopera-
tive years 1 and 5, 31 (12.9%) additional patients experienced
the recurrence of angina. Stenosis or occlusion of a graft was
associated with the recurrence of angina in 18 patients, and
progression of the native coronary artery disease was the
cause of angina in 13 patients.
Discussion
This study produced four main findings. First, the overall pa-
tency rates during the 5 postoperative years after OPCAB
showed different patterns of decrease based on the grafts
used. Second, the LAD territory showed significantly higher
overall patency rates than the LCX and RCA territories in
both 1-year and 5-year angiograms, although the patency
rates were not different in early angiograms. Third, the graft
patency rates during the 5 postoperative years showed differ-
ent patterns of decrease when analyzed by three coronary ter-
ritories. Fourth, the proportion of grade B lesions from the
patent saphenous vein grafts gradually increased, whereas
the proportion of grade B lesions from arterial grafts re-
mained stable during the 5 postoperative years.
With resurgent interest in OPCAB since the mid-1990s,
there have been concerns about accuracy and patency of
the grafts and the long-term outcome. Two meta-analyses
using randomized studies demonstrated that patients under-
going OPCAB demonstrated a lower graft patency than
patients undergoing conventional CABG.3,4 Those differ-
ences were mainly attributable to the lower saphenous vein
or radial artery graft patency rates. A significantly lowered304 The Journal of Thoracic and Cardiovascular Surgery c Febpatency for saphenous vein grafts than for ITA grafts was
suggested to result from the type of graft, presence of hyper-
lipidemia, the exposure and quality of stabilization, and
increased procoagulant activity in OPCAB patients.7,9,10
Another meta-analysis5 that included two more randomized
trials11,12 found a statistically insignificant benefit of conven-
tional CABG over OPCAB for arterial graft patency and a sta-
tistically significant 28% increase in venous graft occlusion
with OPCAB relative to conventional CABG. One study,13
which reviewed the articles published from 1972 through
1998, examined outcomes of left ITA grafting to the LAD.
The early (#1 month postoperatively) and 1-year patency
rates of left ITA grafts in conventional CABG have been
reported to be between 94% and 99% and 88% and 93%,
respectively. The present study showed that the early and
1-year patency rates of left ITA grafting to the LAD in OP-
CAB were 99.5% and 98.2%, respectively, both of which
were not apparently inferior to those of conventional CABG.
In contrast to most of the previous studies investigating
the patency of grafts by cross-sectional study at a specific
time point, we performed coronary angiography in all of
the 240 patients early postoperatively and 1 and 5 years after
OPCAB to trace the changes of the anastomoses and grafts in
the same patient population. In the present serial study, over-
all (grade A1B) graft patency rates early and 1 and 5 years
postoperatively decreased significantly when analyzed by
comparison between early and 1-year rates, and between 1-
year and 5-year rates. We used the c2 test with McNemar ex-
amination, instead of the simple c2 test, because the present
study analyzed the morphologic change of anastomotic sites
in the same patient group. Although ITA grafts demonstrated
a greater than 90% patency rate at 5 years postoperatively, the
patency rate of ITA grafts also decreased significantly during
the follow-up period. RGEA grafts showed a significantly de-
creased patency rate between 1 year and 5 years. Saphenous
vein grafts showed a significantly decreased patency rate dur-
ing the first postoperative year; however, their patency rate
remained stable between 1 year and 5 years. The occlusion
rate of saphenous vein grafts has been reported to be 2% to
2.5% per year between the first and fifth postoperative
years.14 The present study demonstrated that the patency of
vein grafts remained stable during the period (76.0%–
74.4%; P 5 not significant), which was similar to another
serial study for conventional CABG.15 This study supports
the idea that very little change occurs between 1 and 5 years
in the overall patency rate of saphenous vein grafts.16
Like others,17 we demonstrated that graft patency rates of
the LAD territory were higher than those of the LCX or RCA
territories at both 1-year and 5-year angiograms, even though
graft patency rates in the three territories were similar at early
postoperative angiography. In the LAD territory, there were
no significant differences in graft patency rates between early
and 1 year, or between 1 year and 5 years postoperatively. Al-
though the number of saphenous veins grafted for the LADruary 2008
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stable patency during the 5 postoperative years. The RCA ter-
ritory, where grafts other than the ITA graft were commonly
used, showed a lower patency rate than other territories in
some studies.18,19 Other studies20,21 demonstrated lower pa-
tency rates of right ITA grafts in the RCA territory; however,
we did not observe that finding in the RCA territory. Right
ITA grafts demonstrated stable patency rates during the 5
postoperative years. RGEA grafts that were preferentially
used as in situ grafts for revascularization of the RCA terri-
tory showed significantly decreased patency rates between
1 year and 5 years postoperatively despite excellent early
and 1-year patency rates. Saphenous vein grafts showed sig-
nificantly decreased patency rates during the first postopera-
tive year, in contrast to a previous study demonstrating
a comparable patency of saphenous vein grafts to ITA grafts
in the RCA territory.17
When the patency rates were analyzed on the basis of the
proximal technique, in situ left ITA grafts showed signifi-
cantly decreased patency rates during the 5 postoperative
years. Because two thirds (71.9%, 218/303) of in situ left
ITA grafts were used to revascularize the LAD territory
and the remainder for the LCX territory, decreased patency
rates of in situ left ITA grafts in the LCX territory might
have affected the overall patency rate of in situ left ITA
grafts. In the LCX territory, the majority of the left ITA grafts
(98.8%, 85/86) were used as in situ grafts whereas the major-
ity of the right ITA grafts (96.4%, 81/84) were used as com-
posite grafts. In situ left ITA grafts may have to bend
posteriorly and sometimes be pushed by the pericardial mar-
gin when grafting the posterior coronary artery, which may
decrease the patency rate in the LCX territory. On the basis
of our experience, we have changed our revascularization
strategy in OPCAB by avoiding the use of vein grafts if pos-
sible and performing total arterial revascularization using
composite graft rather than bilateral in situ ITA grafts.
The present study demonstrated that the proportion of
grade B arterial grafts (ITA and RGEA) remained stable
(5.1% vs 5.5% vs 6.0%) whereas the proportion of FitzGib-
bon grade B grafts increased in vein grafts (2.6% vs 6.5%
vs 13.3%) during the 5 postoperative years. The decreased
patency of arterial grafts in the present study seemed to be
partly associated with the status of the native coronary artery,
because most late occlusions (9/10) of grade B arterial grafts
at early angiography were associated with moderate stenosis
(,80%) of the native vessel; in contrast, 12 of the 13 newly
developed grade B saphenous vein grafts after 1 year demon-
strated segmental narrowings in the graft trunks, and 1 graft
demonstrated stenosis at the distal anastomosis site. The de-
crease in vein graft patency was suggested to be associated
with disease in the graft itself, demonstrated by segmental
narrowing in the vein graft trunks. All 3 grade B saphenous
vein grafts in the early angiograms demonstrated a stenosis
of more than 50% at the distal anastomosis site. Some ofThe Journal of Thothe anastomotic site stenoses seen in the early angiograms
might result from local tissue edema, because 9 of the 13
anastomotic grade B ITA grafts and all 3 grade B saphenous
vein grafts became grade A at 1 year after surgery.
There are limitations to the present study that must be rec-
ognized. First, the present study was a retrospective observa-
tional study of a single surgeon in a single institution and was
not performed in a randomized manner with regard to the type
of conduits and the target vessels; the majority of ITA grafts
were used to revascularize the left coronary territory and the
majority of RGEA grafts were used to revascularize the
RCA territory. These might serve as confounding variables.
Second, we changed the revascularization strategies during
the study period. A majority of patients who received vein
grafts underwent OPCAB in the early study period and most
patients who received total arterial grafts underwent OPCAB
in the latter part of the study period, which would affect the
results. Third, we might have overestimated the patency rates
by selecting the patients who survived and had angiograms
performed 1 and 5 years after surgery. Fourth, inasmuch as
we performed OPCAB in most patients (77.0%) during the
study period, it was difficult to obtain an on-pump control
group to determine the difference between OPCAB and
on-pump CABG. However, when we compared the present
data with our previous serial study for conventional CABG
(n 5 109),15 there were no differences in 1-year and 5-year
graft patency rates between the OPCAB and conventional
CABG groups (ITA, 95.6% vs 97.9% at 1 year, 92.4% vs
90.3% at 5 years; saphenous vein, 76.0% vs 82.4% at 1
year, 74.4% vs 80.2% at 5 years) (P5 not significant).
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Discussion
Dr Brian F. Buxton (Melbourne, Australia). This paper has some
fascinating aspects to it. One is the sequential rate of angiography
and the second is the excellent results obtained by off-pump surgery.
Let me just run through some of the aspects of this study. This is
a single-center, in fact almost a single-surgeon, retrospective obser-
vational study of 240 out of 402 patients who had off-pump surgery,
60% of whom had repeat angiography unrelated to symptoms. The
sequential angiograms were obtained the day after surgery and at 1
year and 5 years. I will confine most of my comments to the main
groups rather than the subset analyses presented toward the end.
First, the 5-year angiographic patency studies of the ITA grafts
were absolutely excellent, with 92% and 93% 5-year patency for
the OPCAB series. In particular, I noted that most or many of the
right ITA grafts were in situ. In contrast, the RGEA had 83% and
saphenous vein 74% 5-year patency results. There were insufficient306 The Journal of Thoracic and Cardiovascular Surgery c Febradial arteries in this small series to comment on the patency rates.
However, these results overall do confirm the excellent results in
the hands of the Korean surgeons in terms of their OPCAB series.
The second point is that the overall patency in relation to target
arteries provides no real new information. We know that the right
ITA patency is superior to the LCX and RCA, and that was con-
firmed by these studies.
I think of special interest in this paper are the data provided by
the progression of disease in the FitzGibbon 50% stenosis or Fitz-
Gibbon B group. This showed several interesting facts. In some of
the patients the lesions recovered and in other patients new type B
lesions appeared.
Let me run through the progression of disease. The ITA grafts
showed very little progression of disease. There were two time
frames, zero time to 1 year and 1 year through 5 years, and these fail-
ure rates were 4% and 6%, respectively. If we then look at the RGEA
grafts, similar figures were 10% for the first 1-year increment and
then 6% for the 4 years after that. In contrast, the saphenous vein
grafts had double the failure rate of the arterial grafts, even in that
relatively short follow-up period of 5 years.
We noted the same observations in our own series published by
Shah and associates, that is, that there is very little progression of
disease in arterial grafts but quite significant progress in arterial
grafts in a slightly longer follow-up period.
It does appear that saphenous vein graft patency may have im-
proved more recently with careful preparation, use of vasodilators,
adequate storage techniques, and secondary prevention of the pa-
tients after surgery. It may be that this improvement in graft patency,
if it is real, will require longer follow-up of these studies to obtain
sufficient late data.
Let me just run over some of the deficiencies of this excellent
paper. First, it is a single-surgeon, single-institution study, and
one raises the question about generalizability of these results. Are
we always as good as the Koreans?
Second, it is a retrospective study and therefore data quality
comes into question.
I think the most disappointing thing from my perspective is that
there was no comparison between off-pump and on-pump surgery.
There were no control data, which would be absolutely fascinating.
I suspect this could be done in the future prospectively in a way that
would give us some really meaningful answers to the question, is
off-pump surgery patency as good as on-pump? I think that is the
real question that most of us have in mind.
Fourth, there is not really good documentation of the native ves-
sel disease. In other words, how many vessels had serious compet-
itive flow at low-grade stenoses?
I have four questions: What technique did you use to implant the
right ITA? Did you go across the anterior midline or through the
transverse sinus as a Y graft from the left?
Dr Kim. In this series, the right ITA was used to revascularize
the LAD territory by crossing the midline, the ramus, or high obtuse
marginal branch through the transverse sinus, and sometimes the
RCA or posterior descending artery as an in situ graft. If the right
ITA was too short to reach the left coronary territory or if the left cor-
onary territory could not be completely revascularized with bilateral
in situ ITA grafts, a Y graft was constructed.
Dr Buxton. Second question: Most surgeons prefer or perhaps
are more familiar with the Kaplan–Meier estimation of graftruary 2008
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CDpatency, and this can be done at zero time, 1, and 5 years. Why did
you choose to use elective time estimates of 1 and 5 years?
Dr Kim. We studied 240 patients who received all the early, 1-
year, and 5-year follow-up angiograms. For the analysis of the serial
changes over the 5-year period, we used nonparametric c2 test with
McNemar examination. We did not use the Kaplan–Meier estima-
tion because we could not recognize the exact time of graft occlu-
sions.
Dr Buxton. Perhaps there are not so many assumptions made in
your results as ours that might derive from a Kaplan–Meier analysis.
One of the difficult things about looking at graft angiograms, and
particularly anastomotic lesions and stenoses, is the validity and re-
producibility of the observations. Can you tell us how many people
looked and how independent the observers were in assessing the
level of graft stenoses?
Dr Kim. Our cardiologists performed the angiograms and put
their initial interpretations. For this study, one physician initially re-
viewed all the angiograms and consensus was reached after review.
Dr Buxton. One last question: Forty percent of the patients had
missing data. Is there any reason for that? Did their grafts all fail?
What happened? Why were they missing?
Dr Kim. As I mentioned before, patients who missed any of the
three postoperative serial angiograms were excluded from this
study. In this study, 240 patients who received all three follow-up
angiograms—early, 1 year, and 5 years—evaluation of the anasto-
motic sites and patency of the grafts, were studied.
Dr Volkmar Falk (Leipzig, Germany). I enjoyed your paper,
and I have one question. Would it be of value to go back and assess
the extent of coronary artery disease by applying the SYNTAX
score, which was designed to measure the extent of coronary artery
disease? You are in a unique position in that you have angiograms at
the time of surgery and 5 years after. You could finally tell us
whether the extent of coronary artery disease at the time of surgery
is really a predictor of late graft failure. That is one question that is
still kind of open and no one is really addressing this. Would you
consider doing that? I think this would be a great adjunct to your
current study.The Journal of ThoDr Damiano. Can you clarify what you mean by SYNTAX
score?
Dr Falk. I’m sorry; I thought that was common knowledge al-
ready. The SYNTAX trial was designed to compare treatment of tri-
ple vessel disease either by stenting or CABG. It was just finished,
so the enrollment is just finished. Specifically for this trial, a new
scoring system was developed to determine the extent of coronary
artery disease, because most of the trials do not really look at this.
Let’s say they enroll patients with triple vessel disease, but we all
know that there are various types of triple vessel disease that may
alter the outcome more so than any of the other risk factors that
are commonly applied, such as diabetes or hypertension. The extent
of coronary artery disease can be graded. There is a good score for
this that was actually designed for the SYNTAX trial but is avail-
able. It should be great to look at your angiograms again, apply
the score, and then after a period of time assess whether the extent
of coronary artery disease plays a role for late graft occlusion.
Dr Damiano. It is a good idea, but I think he will probably
have to go back and get the score and then report the data at a later
meeting.
Dr Kim. I would like to make some comments. As Dr Buxton
indicated, there are limitations to the present study. It was a retro-
spective study of a single surgeon in a single institution. It was
not performed in a randomized manner with regard to the type of
conduit and the target vessels. The majority of ITA grafts were
used to revascularize the left coronary territory and the majority of
RGEA grafts were used to revascularize the RCA territory. This
might serve as confounding variables. We have two staff surgeons
in the adult cardiac division of our institution. I do most of the iso-
lated CABGs with off-pump technique and the other surgeon does
most of the valvular and aortic operations. That is why this study
was a single-surgeon experience from a single institution. As we
performed OPCAB in most of patients during the study period, it
was difficult to obtain an on-pump control group to see the differ-
ence between off-pump and on-pump CABG.racic and Cardiovascular Surgery c Volume 135, Number 2 307
